# Ironwood Capital

> Ironwood Capital is a VC fund in Avon backing Biotechnology and Health Care. See 37 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Avon, United States
- Total investments: 37
- Last investment: Mar 2025
- Lead investor: 22%
- Last fund: Jul 2018
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/company/ironwood-capital
- Website: http://www.ironwoodcap.com

Ironwood Capital is a private equity firm that provides non-control growth capital solutions to middle-market businesses.The firm invests in the form of subordinated debt and preferred stock in amounts ranging from $5 million to $20 million to support business owners and financial sponsors in growth financings, full and partial recapitalizations,generational transitions, and buyouts.Ironwood Capital was founded in 1985 and is based in Avon, Connecticut.

## Contacts

5 contacts available for Ironwood Capital. Shizune tracks 8 team members at Ironwood Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/ironwood-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 16% |
| Health Care | 5 | 14% |
| Manufacturing | 5 | 14% |
| Software | 3 | 8% |
| FinTech | 2 | 5% |

54 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Private Equity | 14 | 38% |
| Seed | 4 | 11% |
| Series B | 4 | 11% |
| Funding Round | 4 | 11% |
| Series A | 3 | 8% |

8 stages tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Carolyn Galiette | Founding Partner, President and Chief Investment Officer | 0 | https://shizune.co/investors/profile/carolyn-galiette |
| Dickson Suit | Partner | 1 | https://shizune.co/investors/profile/dickson-suit |
| Ellen Stotletr | Chief Compliance Officer and VP of Investment Operation | 0 | https://shizune.co/investors/profile/ellen-stotletr |
| Jim Barra | Partner and Chief Operating Officer | 0 | https://shizune.co/investors/profile/jim-barra |
| John Strahley | Managing Director | 0 | https://shizune.co/investors/profile/john-strahley |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| H3 Manufacturing Group | H3 Manufacturing Group manufactures CNC machining, sheet metal fabrication and provides welding, finishing, and assemblies for industries. |  | Private Equity | Mar 07, 2025 |  |
| Elite Equipment Rentals | Elite Equipment Rentals provides specialized equipment rentals, parts, and service solutions across multiple industries in the U.S. |  | Debt Financing | May 20, 2024 |  |
| Elite Equipment Rentals | Elite Equipment Rentals provides specialized equipment rentals, parts, and service solutions across multiple industries in the U.S. |  | Private Equity | May 20, 2024 |  |
| Modifi Bio | Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drugdevelopment methods. | $4.3M | Seed | Oct 16, 2023 |  |
| Le Sueur Incorporated | Le Sueur Incorporated is a mining & metals company offering sand casting, permanent mold, and die casting. |  | Debt Financing | Jan 05, 2023 |  |
| Le Sueur Incorporated | Le Sueur Incorporated is a mining & metals company offering sand casting, permanent mold, and die casting. |  | Private Equity | Jan 05, 2023 |  |
| Modifi Bio | Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics. The company's strategy for combating cancer centers around modifying tumor DNA in a way that renders cancer cells irreparable while preserving the integrity of healthy cells. This unique approach empowers researchers to disrupt traditional oncology drugdevelopment methods. | $6.4M | Seed | Jul 28, 2022 |  |
| Directional Services | Directional Services is a full service licensed electrical & utility contractor providing specialized services electrical solar construction |  | Private Equity | Jun 07, 2022 |  |
| Torigen Pharmaceuticals | Torigen Pharmaceuticals focuses on providing cancer care solutions for animals. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation.The company was founded in 2013 by Ashley Kalinauskas and Mark Suckow and is based inFarmington, Connecticut, United States. | $13M | Series A | May 24, 2022 |  |
| P2 Science | P2 Science a venture-backed, renewable specialty chemicals company, co-founded by Yale scientists, a chemical industry CEO and Elm Street Ventures, an early-stage venture fund. P2 Science has developed a unique process technology for converting renewable feedstocks—including vegetable oils—into high-value, specialty chemicals. These includeflavor, fragrance and cosmetics ingredients. Many of their products are today available only from petrochemical sources. Among the first products to be produced by P2 are vegetable-derived, cost-effective versions of current petrochemical fragrance ingredients. Major users and formulators of specialty chemicals have a strong interest in substituting renewable for petrochemical ingredients. Patrick Foley, a Yale graduate of the PhD program in Environmental Engineering, is P2′s Chief Scientific Officer. Neil Burns, an executive with 20+ years experience in the specialty chemical industry, is the company’s CEO. P2 has a laboratory in New Haven, CT to support this technology’s development and commercialization, as well as partnerships with major companies at a number of points along the supply chain. | $12M | Series C | Jan 29, 2020 |  |

10 of 37 investments shown.

## Co-investors
- [Advantage Capital](https://shizune.co/investors/profile/advantage-capital-partners) — VC Fund, 11 deals together
- [Connecticut Innovations](https://shizune.co/investors/profile/connecticut-innovations) — VC Fund, 10 deals together
- [Spring Mountain Capital](https://shizune.co/investors/profile/spring-mountain-capital) — VC Fund, 3 deals together
- [BASF Venture Capital](https://shizune.co/investors/profile/basf-venture-capital) — VC Fund, 2 deals together
- [Elm Street Ventures](https://shizune.co/investors/profile/elm-street-ventures) — VC Fund, 2 deals together
- [Genesis Park](https://shizune.co/investors/profile/genesis-park) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Foresight Group](https://shizune.co/investors/profile/foresight-group) — VC Fund
- [YFM Equity Partners](https://shizune.co/investors/profile/yfm-equity-partners) — VC Fund
- [Fondaction](https://shizune.co/investors/profile/fondaction) — VC Fund

## FAQ

### What does Ironwood Capital invest in?

Ironwood Capital invests primarily in Biotechnology, Health Care and Manufacturing startups, most often at Private Equity and Seed stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Ironwood Capital?

Public channels for Ironwood Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Ironwood Capital?

The team at Ironwood Capital includes Carolyn Galiette (Founding Partner, President and Chief Investment Officer), Dickson Suit (Partner) and Ellen Stotletr (Chief Compliance Officer and VP of Investment Operation), among 8 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co